Literature DB >> 27490659

Clinical Features of Respiratory Viral Infections Among Inpatients at a Major US Tertiary Care Hospital.

Prashant Malhotra1, Arthur Luka1, Carla S McWilliams1, Kaitlin G Poeth1, Rebecca Schwartz1, Mohammed Elfekey1, Sandy Balwan1.   

Abstract

OBJECTIVES: Respiratory viral illnesses (RVI) are reliably diagnosed by respiratory viral panel using polymerase chain reaction (RVP-PCR); however, owing to the scant data, clinical presentation alone is unreliable in establishing viral etiology. The primary objective of this study was to characterize signs and symptoms of RVI among inpatients in a major tertiary care hospital.
METHODS: Between 2013 and 2015, adult inpatients with RVI undergoing RVP-PCR were prospectively enrolled in our study. Clinical data were collected by interviews and electronic medical record reviews. Data analysis was performed using χ(2) testing, analysis of variance for continuous variables, and logistic regression modeling.
RESULTS: Of 421 patients analyzed, 175 (41.7%) had a positive RVP-PCR. Patients were evenly matched at baseline except for renal disease. Multivariate logistic regression modeling demonstrated the following positive correlations: positive RVP-PCR with renal disease (odds ratio [OR] 2.08), cough (OR 2.28), and wheezing (OR 1.8); influenza with cough (OR 5.04), and renal disease (OR 2.17); metapneumovirus with age older than 65 (OR 3.24); respiratory syncytial viruses with wheezing (OR 3.42) and immunosuppression (OR 3.11); and parainfluenza with smoking (OR 3.16). Negative correlations included influenza with anosmia (OR 0.41); rhinovirus/enterovirus with feeling confined to bed (OR 0.3); metapneumovirus with smoking (OR 0.29); and parainfluenza with male sex (OR 0.22).
CONCLUSIONS: In this descriptive study, we noted specific viral associations with clinical signs and symptoms among 421 inpatients with RVIs. With increasing RVP-PCR use, studies similar to ours may be able to better define the clinical presentation of RVIs and lead to evidence-based, clinical presentation-guided diagnostic and management algorithms.

Entities:  

Mesh:

Year:  2016        PMID: 27490659     DOI: 10.14423/SMJ.0000000000000503

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  Hypogeusia as the initial presenting symptom of COVID-19.

Authors:  Lauren E Melley; Eli Bress; Erik Polan
Journal:  BMJ Case Rep       Date:  2020-05-13

Review 2.  Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection.

Authors:  Wilson P Lao; Sarah A Imam; Shaun A Nguyen
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-04-17

Review 3.  Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?

Authors:  Ming Zeng; De-Yun Wang; Joaquim Mullol; Zheng Liu
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-03       Impact factor: 4.806

4.  Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China.

Authors:  Jia Song; Yi-Ke Deng; Hai Wang; Zhi-Chao Wang; Bo Liao; Jin Ma; Chao He; Li Pan; Yang Liu; Isam Alobid; De-Yun Wang; Ming Zeng; Joaquim Mullol; Zheng Liu
Journal:  Curr Med Sci       Date:  2021-02-13

5.  Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan.

Authors:  Meng-Yu Cheng; Wen-Hsin Hsih; Mao-Wang Ho; Yi-Chyi Lai; Wei-Chih Liao; Chih-Yu Chen; Tsung-Chia Chen; Yu-Lin Lee; Po-Yu Liu; Chih-Chuan Kao; Chia-Huei Chou; Po-Chang Lin; Chih-Yu Chi; Lih-Ying Leong; Chih-Jaan Tai; Min-Chi Lu
Journal:  J Microbiol Immunol Infect       Date:  2021-02-08       Impact factor: 4.399

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.